Hypermethylation of synphilin-1, alpha-synuclein-interacting protein (SNCAIP) gene in the cerebral cortex of patients with sporadic Parkinson’s disease

Khashayar Dashtipour, Ali Tafreshi, Charles Howard Adler, Thomas Beach, Xin Chen, Geidy Serrano, Stephanie Tashiro, Charles Wang

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Objective: To determine and compare DNA methylation patterns between patients with Parkinson’s disease (PD) and age- and sex-similar matched non-PD controls. Background: Epigenetic regulation is one of the major mechanisms for an organism to respond to the environment through changes in gene expression and has been implicated in numerous disease processes. We would like to examine epigenetic modification patterns that may predispose or protect against PD. Methods: Frozen tissue samples of the human cerebral cortex from 12 PD patients and 12 subjects without PD pathology were obtained. Genome-wide DNA methylation profiling was performed using the Illumina HumanMethylation450 BeadChip array. Differential methylation was defined as a mean methylation level difference (delta β) of at least 0.20 (Δβ ≥ 0.20). Methylation regions with an absolute delta β value ≥ 0.20 were selected for further gene function studies. Results: We identified 2795 differentially methylated CpG sites in the frontal cortex of PD cases with a detection p-value of ≤ 0.01 and 328 differentially methylated CpG sites with a detection p-value of ≤ 0.001. A pattern of robust hypermethylation of synphilin-1, α-synuclein-interacting protein (SNCAIP) gene was found in the brain of PD cases (p = 4.93 × 10-7 and delta β = 0.60). Conclusion: Our findings support a link between SNCAIP methylation and PD risk. Hypomethylation of SNCAIP may function to protect against PD. The current results may suggest that the methylation status of SNCAIP could be useful as a marker in PD diagnosis and treatment and warrants further investigation.

Original languageEnglish (US)
Article number74
JournalBrain Sciences
Volume7
Issue number7
DOIs
StatePublished - Jul 1 2017

Fingerprint

alpha-Synuclein
Cerebral Cortex
Parkinson Disease
Synucleins
Methylation
Proteins
DNA Methylation
Epigenomics
DNA Fingerprinting
Brain Diseases
Frontal Lobe
Genome
Pathology
Gene Expression

Keywords

  • DNA methylation
  • Epigenetics
  • Genetics
  • Parkinson’s disease
  • SNCAIP
  • Synphilin-1

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Hypermethylation of synphilin-1, alpha-synuclein-interacting protein (SNCAIP) gene in the cerebral cortex of patients with sporadic Parkinson’s disease. / Dashtipour, Khashayar; Tafreshi, Ali; Adler, Charles Howard; Beach, Thomas; Chen, Xin; Serrano, Geidy; Tashiro, Stephanie; Wang, Charles.

In: Brain Sciences, Vol. 7, No. 7, 74, 01.07.2017.

Research output: Contribution to journalArticle

Dashtipour, Khashayar ; Tafreshi, Ali ; Adler, Charles Howard ; Beach, Thomas ; Chen, Xin ; Serrano, Geidy ; Tashiro, Stephanie ; Wang, Charles. / Hypermethylation of synphilin-1, alpha-synuclein-interacting protein (SNCAIP) gene in the cerebral cortex of patients with sporadic Parkinson’s disease. In: Brain Sciences. 2017 ; Vol. 7, No. 7.
@article{fafa72ee330a443d9862fff6541c5454,
title = "Hypermethylation of synphilin-1, alpha-synuclein-interacting protein (SNCAIP) gene in the cerebral cortex of patients with sporadic Parkinson’s disease",
abstract = "Objective: To determine and compare DNA methylation patterns between patients with Parkinson’s disease (PD) and age- and sex-similar matched non-PD controls. Background: Epigenetic regulation is one of the major mechanisms for an organism to respond to the environment through changes in gene expression and has been implicated in numerous disease processes. We would like to examine epigenetic modification patterns that may predispose or protect against PD. Methods: Frozen tissue samples of the human cerebral cortex from 12 PD patients and 12 subjects without PD pathology were obtained. Genome-wide DNA methylation profiling was performed using the Illumina HumanMethylation450 BeadChip array. Differential methylation was defined as a mean methylation level difference (delta β) of at least 0.20 (Δβ ≥ 0.20). Methylation regions with an absolute delta β value ≥ 0.20 were selected for further gene function studies. Results: We identified 2795 differentially methylated CpG sites in the frontal cortex of PD cases with a detection p-value of ≤ 0.01 and 328 differentially methylated CpG sites with a detection p-value of ≤ 0.001. A pattern of robust hypermethylation of synphilin-1, α-synuclein-interacting protein (SNCAIP) gene was found in the brain of PD cases (p = 4.93 × 10-7 and delta β = 0.60). Conclusion: Our findings support a link between SNCAIP methylation and PD risk. Hypomethylation of SNCAIP may function to protect against PD. The current results may suggest that the methylation status of SNCAIP could be useful as a marker in PD diagnosis and treatment and warrants further investigation.",
keywords = "DNA methylation, Epigenetics, Genetics, Parkinson’s disease, SNCAIP, Synphilin-1",
author = "Khashayar Dashtipour and Ali Tafreshi and Adler, {Charles Howard} and Thomas Beach and Xin Chen and Geidy Serrano and Stephanie Tashiro and Charles Wang",
year = "2017",
month = "7",
day = "1",
doi = "10.3390/brainsci7070074",
language = "English (US)",
volume = "7",
journal = "Brain Sciences",
issn = "2076-3425",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "7",

}

TY - JOUR

T1 - Hypermethylation of synphilin-1, alpha-synuclein-interacting protein (SNCAIP) gene in the cerebral cortex of patients with sporadic Parkinson’s disease

AU - Dashtipour, Khashayar

AU - Tafreshi, Ali

AU - Adler, Charles Howard

AU - Beach, Thomas

AU - Chen, Xin

AU - Serrano, Geidy

AU - Tashiro, Stephanie

AU - Wang, Charles

PY - 2017/7/1

Y1 - 2017/7/1

N2 - Objective: To determine and compare DNA methylation patterns between patients with Parkinson’s disease (PD) and age- and sex-similar matched non-PD controls. Background: Epigenetic regulation is one of the major mechanisms for an organism to respond to the environment through changes in gene expression and has been implicated in numerous disease processes. We would like to examine epigenetic modification patterns that may predispose or protect against PD. Methods: Frozen tissue samples of the human cerebral cortex from 12 PD patients and 12 subjects without PD pathology were obtained. Genome-wide DNA methylation profiling was performed using the Illumina HumanMethylation450 BeadChip array. Differential methylation was defined as a mean methylation level difference (delta β) of at least 0.20 (Δβ ≥ 0.20). Methylation regions with an absolute delta β value ≥ 0.20 were selected for further gene function studies. Results: We identified 2795 differentially methylated CpG sites in the frontal cortex of PD cases with a detection p-value of ≤ 0.01 and 328 differentially methylated CpG sites with a detection p-value of ≤ 0.001. A pattern of robust hypermethylation of synphilin-1, α-synuclein-interacting protein (SNCAIP) gene was found in the brain of PD cases (p = 4.93 × 10-7 and delta β = 0.60). Conclusion: Our findings support a link between SNCAIP methylation and PD risk. Hypomethylation of SNCAIP may function to protect against PD. The current results may suggest that the methylation status of SNCAIP could be useful as a marker in PD diagnosis and treatment and warrants further investigation.

AB - Objective: To determine and compare DNA methylation patterns between patients with Parkinson’s disease (PD) and age- and sex-similar matched non-PD controls. Background: Epigenetic regulation is one of the major mechanisms for an organism to respond to the environment through changes in gene expression and has been implicated in numerous disease processes. We would like to examine epigenetic modification patterns that may predispose or protect against PD. Methods: Frozen tissue samples of the human cerebral cortex from 12 PD patients and 12 subjects without PD pathology were obtained. Genome-wide DNA methylation profiling was performed using the Illumina HumanMethylation450 BeadChip array. Differential methylation was defined as a mean methylation level difference (delta β) of at least 0.20 (Δβ ≥ 0.20). Methylation regions with an absolute delta β value ≥ 0.20 were selected for further gene function studies. Results: We identified 2795 differentially methylated CpG sites in the frontal cortex of PD cases with a detection p-value of ≤ 0.01 and 328 differentially methylated CpG sites with a detection p-value of ≤ 0.001. A pattern of robust hypermethylation of synphilin-1, α-synuclein-interacting protein (SNCAIP) gene was found in the brain of PD cases (p = 4.93 × 10-7 and delta β = 0.60). Conclusion: Our findings support a link between SNCAIP methylation and PD risk. Hypomethylation of SNCAIP may function to protect against PD. The current results may suggest that the methylation status of SNCAIP could be useful as a marker in PD diagnosis and treatment and warrants further investigation.

KW - DNA methylation

KW - Epigenetics

KW - Genetics

KW - Parkinson’s disease

KW - SNCAIP

KW - Synphilin-1

UR - http://www.scopus.com/inward/record.url?scp=85021722394&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021722394&partnerID=8YFLogxK

U2 - 10.3390/brainsci7070074

DO - 10.3390/brainsci7070074

M3 - Article

AN - SCOPUS:85021722394

VL - 7

JO - Brain Sciences

JF - Brain Sciences

SN - 2076-3425

IS - 7

M1 - 74

ER -